DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a complex condition that displays heterogeneity in disease severity and response to standard treatments between patients. Failure rates for conventional, target synthetic, and biologic disease-modifying rheumatic drugs (DMARDs) are significant. Although there are models...

Full description

Bibliographic Details
Main Authors: Susan Siyu Wang, Myles J. Lewis, Costantino Pitzalis
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Biomedicines
Subjects:
DNA methylation
rheumatoid arthritis
anti-TNF therapy
biologic therapy
DMARDs
treatment response
Online Access:https://www.mdpi.com/2227-9059/11/7/1987

Internet

https://www.mdpi.com/2227-9059/11/7/1987

Similar Items